Kristian Reich is CSO at MoonLake Immunotherapeutics (MLTX). They have made 1 open-market trade across 1 company since 2024, most recently 2026-07-27.
CIK 0001920553
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MLTX | 2,711,198 | $25.9M |
Shares reported on the most recent Form 4, priced at the 2026-07-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MLTX | SELL · 10b5-1 | 2026-07-27 | 2026-07-29 | $20.00 | $22K | -6.0% | -18.9% | — |
| MLTX | SELL · 10b5-1 | 2026-07-21 | 2026-07-23 | $20.02 | $1.0M | -6.7% | -20.0% | — |
| MLTX | SELL · 10b5-1 | 2026-07-20 | 2026-07-21 | $20.09 | $878K | -7.8% | -20.7% | — |
| MLTX | SELL · 10b5-1 | 2026-07-15 | 2026-07-20 | $20.01 | $322K | -1.4% | -12.9% | — |
| MLTX | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $19.01 | $2.9M | -1.2% | -0.1% | -38.1% |
| MLTX | SELL | 2025-12-08 | 2025-12-10 | $14.74 | $4.1M | -6.6% | +28.0% | +27.0% |
| MLTX | SELL · 10b5-1 | 2024-02-27 | 2024-02-29 | $55.00 | $6.5M | -7.2% | -2.0% | -17.2% |
| MLTX | SELL · 10b5-1 | 2024-02-20 | 2024-02-22 | $57.33 | $1.2M | -8.4% | -1.4% | -24.0% |
| MLTX | SELL · 10b5-1 | 2024-02-14 | 2024-02-16 | $61.07 | $3.1M | -18.4% | -17.8% | -30.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.